ckd-387
Small moleculeexperimental
Clinical trial activity
7 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
7
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Aug 30, 2018 (NCT03646799)
Timeline
2010s
- Jan 1, 2018
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- UnclearUnclear
Unclear unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05673369 | Phase 1 | Jan 4, 2023 | Chong Kun Dang Pharmaceutical |
| NCT06399068 | Phase 1 | Sep 19, 2022 | Chong Kun Dang Pharmaceutical |
| NCT06399055 | Phase 1 | Sep 16, 2022 | Chong Kun Dang Pharmaceutical |
| NCT03849339 | Phase 1 | Jan 28, 2019 | Chong Kun Dang Pharmaceutical, Yonsei University |
| NCT03849261 | Phase 1 | Jan 14, 2019 | Chong Kun Dang Pharmaceutical, Yonsei University |
| NCT03738449 | Phase 1 | Jan 8, 2019 | Chong Kun Dang Pharmaceutical, Yonsei University |
| NCT03646799 | Phase 1 | Aug 30, 2018 | Chong Kun Dang Pharmaceutical, Yonsei University |
Showing 7 of 7 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Chong Kun Dang Pharmaceutical | For profit | 7 | 7 | 1 | 2018 |
| Yonsei University | Academic/Hospital | 4 | 0 | 1 | 2018 |
2 organizations
Page 1 / 1